Sort
82,697 grants matching “vaccine development”
Core C
$753,572Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2020 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$753,566Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
$753,536Igor Kramnik · Boston University Medical Campus · R01 · FY2016 · HL
Type 1 Diabetes-A Proposal for Prevention & Intervention
$753,507Antoinette M Moran · University Of Minnesota · U01 · FY2014 · DK
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
$753,498Courtney V. Fletcher · University Of Nebraska Medical Center · R01 · FY2017 · AI
Task 02 (B01): Clinical Isolate Panels for Selected Bacterial Pathogens
$753,491Uk Health Security Agency · N01 · FY2009 · AI
Interruption of maternal-fetal transmission of HIV
$753,476Joseph M McCune · University Of California, San Francisco · R01 · FY2011 · AI
Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)
$753,446Karsten Lunze · Boston Medical Center · R01 · FY2025 · CA
Mycology Research Unit: In Vivo Induced Fungal Antigens
$753,431University Of Florida · P01 · FY2004 · AI
Prevention of Primary HCMV Infection by Vaccinating against HCMV-Encoded IL-10
$753,403Peter A Barry · University Of California At Davis · R01 · FY2014 · AI
Modulation of Viral Antigen Presentation in the Lung
$753,402Anna Karolina Palucka · Jackson Laboratory · U19 · FY2021 · AI
Role of gamma/delta T cells in Vaccine Induced Immunity
$753,335Daniel F. Hoft · Saint Louis University · R01 · FY2019 · AI
Clinical Development of Chimp Adenovirus Vectors
$753,266Hildegund C. J. Ertl · Wistar Institute · U19 · FY2010 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$753,235Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2020 · AI
A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage
$753,210Robert A. Bednarczyk · Emory University · R01 · FY2019 · AI
Universal T cell targeted influenza vaccine
$753,206Daniel F. Hoft · Saint Louis University · R01 · FY2021 · AI
Impact of eliminating nonmedical exemptions in California
$753,205Saad B. Omer · Emory University · R01 · FY2018 · AI
A novel APOBEC-based vaccine approach for HIV
$753,200Douglas F Nixon · George Washington University · R33 · FY2015 · AI
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$753,094Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2025 · AI
Core B - MappBiopharmaceutical, Inc.
$753,083Larry Zeitlin · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Previous exposure to dengue as a risk factor for Zika virus during pregnancy
$753,026Matthew T Aliota · University Of Wisconsin-Madison · R56 · FY2017 · AI
Innate Restriction Factor Modulation of Retrovirus-specific Humoral Immunity
$752,904Mario Luis Santiago · University Of Colorado Denver · R01 · FY2010 · AI
Prime shock and kill for HIV erradication
$752,862Andrew D Badley · Mayo Clinic Rochester · R01 · FY2019 · AI
Prime shock and kill for HIV erradication
$752,862Andrew D Badley · Mayo Clinic Rochester · R01 · FY2020 · AI
Prime shock and kill for HIV erradication
$752,862Andrew D Badley · Mayo Clinic Rochester · R01 · FY2021 · AI